查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828089

2025年人工器官和仿生学全球市场报告

Artificial Organ And Bionics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，人工器官和仿生学市场规模强劲成长，从2024年的328.2亿美元增加至2025年的358.6亿美元，复合年增长率为9.3%。预测期内的成长归因于慢性病发病率的上升、医学创新与研究、移植接受度的提高、政府措施和资金投入以及生物相容性的提高。

预计未来几年人工器官和仿生市场将快速成长，到2029年将达到561.1亿美元，复合年增长率为11.8%。预测期内的成长归因于医疗保健支出的增加、个人化医疗、简化的监管支援和核准、3D列印技术的快速发展以及合作研究和伙伴关係。预测期内的主要趋势包括微型化和穿戴式技术、技术进步、尖端材料的整合、设计中的人工智慧和机器学习，以及3D列印和生物列印技术的进步。

人工器官和仿生学涵盖旨在取代缺失或缺失的人体器官功能的机器或装置，而仿生学则涉及建构能够反映生物体某些特性的人工系统。仿生学的主要目标是延长人类寿命并提升其功能。

该领域的关键产品包括人工器官和仿生学。人工器官是用来重建缺失或受损人体器官或身体部位功能的装置。人工器官分为植入式和体外式，并进一步细分为心臟仿生学和脑仿生学。该领域涵盖的技术包括机械仿生学和电子仿生学。

2025年春季美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供人工器官和仿生学市场统计数据，包括全球市场规模、区域份额、竞争对手的人工器官和仿生学市场份额、详细的人工器官和仿生学细分市场、市场趋势和商业机会，以及在人工器官和仿生学行业取得成功所需的数据。这份人工器官和仿生学市场研究报告提供了所有必要资讯的完整展望，并详细分析了该行业的现状和未来前景。

未来五年的预测成长率为11.8%，较我们先前对该市场的预测略有下降0.1%。下降的主要原因是美国与其他国家之间的关税影响。美国可能会直接感受到这种影响，因为德国製造的生物相容性膜和瑞士製造的精密微泵的供不应求，这可能会延缓挽救生命的植入手术和仿生肢体的研发。此外，互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响也将对全球经济和贸易产生更广泛的负面影响。

预计未来几年，不断增长的医疗保健支出将推动人造器官和仿生学市场的成长。医疗保健支出包括医疗保健及相关活动的总支出，例如私人和公共医疗保险、健康研究和公共卫生计划。医疗保健投资刺激了技术创新，从而开发出更先进、更有效率的人造器官。这包括材料、设计和製造流程的改进。例如，美国联邦政府机构医疗保险和医疗补助服务中心在2023年12月报告称，美国国家医疗保健支出将在2022年增长4.3%，高于2021年的2.7%。因此，不断增长的医疗保健支出正在推动人造器官和仿生学市场的发展。

预计未来移植数量的增加将推动人造器官和仿生学市场的成长。移植是指将组织或器官从捐赠者转移到接受者，或从身体的一部分转移到另一部分的外科手术。人造器官是植入体内以取代受损器官并复製其特定功能，使患者能够过正常生活的装置。例如，2024 年 1 月，美国器官取得和移植网络 (OPTN) 报告称，2023 年总合进行了 46,632 例活体和已故捐赠者的器官移植。与 2022 年相比增长了 8.7%，比 2021 年增长了 12.7%，2021 年首次超过 40,000 例。其中，39,679 例移植来自已故捐赠者，比前一年增加 8.9%，连续第 11 年创下纪录。因此，预计移植数量的增加将显着推动人工器官和仿生学市场的发展。

来自领先公司的投资正在推动人工器官仿生市场器官移植的转型。这些投资在推动人工器官发展方面发挥关键作用，透过开发功能性、生物相容性的替代品来解决捐赠器官短缺的问题。这不仅为等待器官移植的患者带来了希望，也有可能改变移植照护的模式。例如，2022年4月，加拿大政府投资200万美元用于一项创新的器官和组织捐赠计划，旨在提高加拿大器官捐赠和移植的效率。这笔资金与致力于支持器官捐赠和移植研究的「卓越中心网络」计划一致。

人工器官和仿生市场的主要企业正在推动助听器等技术的发展，这些技术可以增强连接性、改善用户体验并实现跨各种设备的无缝整合。听力技术包括旨在帮助残障人士的设备和解决方案，例如助听器和人工电子耳。例如，2022 年 11 月，总部位于澳洲的医疗设备公司 Cochlear Limited 的 Nucleus 8 声音处理器获得了美国食品药物管理局(FDA) 的核准。该设备旨在提供用户友好的功能，包括改进的音质、增强的连接性以及与蓝牙 LE 音讯技术的兼容性。这项创新允许用户无线连接到多个设备，例如智慧型手机和电视，以获得更整合和简化的聆听体验。

2022年12月，美国知名医疗保健产品公司强生公司成功收购了Abiomed，收购金额未揭露。此次策略性收购将使强生公司能够提供尖端医疗技术，并在全球范围内推进其医疗科技业务。美国Abiomed公司专注于人工器官和仿生学领域，此次收购对强生公司而言意义重大，旨在进一步加强其在该领域的影响力和创新能力。

人工器官和仿生学市场的主要企业包括 Abiomed Inc.、Asahi Kasei Medical Co., Ltd、Baxter、Berlin Heart GmbH、Boston Scientific Corporation、Cyber​​onics Inc、Getinge、Medtronic PLC、Bornlife Prosthetic and Orthotic Inc、Sonova、LifeNet Health、Terumd、tat. Limited、Advanced Bionics AG、Ottobock SE & Co.KGaA、Second Sight Medical Products Inc.、iWalk Inc.、Jarvik Heart Inc.、St. Jude Medical Inc.、Harmonic Bionics Inc.、Open Bionics、Beta Bionics Inc.、Bionic Prosthetics and Orthotics and Orthoics and Orthoics、Mobius Bulics.

2024年，北美是人工器官和仿生学市场最大的地区。预计亚太地区将成为预测期内人工器官和仿生学全球市场报告中成长最快的地区。这份人工器官和仿生学市场报告涵盖亚太地区、西欧、东欧、北美、南美以及中东和非洲。

人工器官和仿生市场报告涵盖的国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、英国、美国、义大利、西班牙

人工器官仿生市场包括人工心臟、全人工心臟 (TAH)、人工肾臟、人工肝臟、耳部仿生、视觉仿生、整形外科仿生和心臟仿生的销售。此市场的价值是指“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球人工器官与仿生学：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球人工器官与仿生市场：成长率分析
  • 全球人工器官与仿生学市场表现：规模与成长，2019-2024
  • 全球人工器官与仿生学市场预测：规模与成长，2024-2029年，2034年
  • 全球人工器官与仿生学：总目标市场（TAM）

第六章 市场细分

  • 全球人工器官和仿生学市场（按产品、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 人造器官
  • 仿生学
  • 全球人工器官和仿生学市场（按固定类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 可植入和外戴
  • 心臟仿生学与脑仿生学
  • 全球人工器官和仿生学市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 机械仿生学
  • 电子仿生学
  • 人工器官与仿生学
  • 全球人工器官和仿生市场：人工器官细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 人工心臟
  • 人工肾
  • 人工肝
  • 人工胰臟
  • 人工肺
  • 全球人工器官与仿生学市场：仿生学细分市场、类型、表现与预测，2019-2024 年、2024-2029 年、2034 年
  • 仿生肢体
  • 仿生眼
  • 外骨骼
  • 神经假体

第七章 区域和国家分析

  • 全球人工器官和仿生学市场：2019-2024 年、2024-2029 年和 2034 年区域表现和预测
  • 全球人工器官及仿生学市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 人工器官与仿生学市场：竞争格局
  • 人工器官和仿生学市场：公司简介
    • Abiomed Inc.
    • Asahi Kasei Medical Co., Ltd
    • Baxter
    • Berlin Heart GmbH
    • Boston Scientific Corporation

第31章：其他领先和创新企业

  • Cyberonics Inc.
  • Ekso Bionics Holdings Inc.
  • Getinge AB
  • Medtronic PLC
  • Bornlife Prosthetic and Orthotic Inc.
  • Sonova
  • LifeNet Health
  • Terumo Corporation
  • Nano Retina Ltd
  • Edwards Lifesciences Corporation
  • Orthofix Medical Inc
  • Cochlear Limited
  • Advanced Bionics AG
  • Ottobock SE & Co. KGaA
  • Second Sight Medical Products Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年人工器官和仿生学市场：提供新机会的国家
  • 2029年人工器官与仿生市场：细分领域带来新机会
  • 2029年人工器官与仿生学市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r23939u

Artificial organs and bionics encompass machines or devices designed to substitute the functions of a deficient or absent human organ, while bionics involves constructing artificial systems mirroring certain characteristics of living organisms. Their primary objective is to enhance an individual's lifespan and functionality.

Within this domain, the main products include artificial organs and artificial bionics. Artificial organs are devices utilized to replicate the functions of missing or impaired human organs or body parts. These can be categorized based on fixation types as either implantable or externally-worn, and further segmented into cardiac bionics and brain bionics. The technologies encompassed within this field encompass mechanical bionics and electronic bionics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The artificial organ and bionics market research report is one of a series of new reports from The Business Research Company that provides artificial organ and bionics market statistics, including artificial organ and bionics industry global market size, regional shares, competitors with an artificial organ and bionics market share, detailed artificial organ and bionics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial organ and bionics industry. This artificial organ and bionics market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial organ and bionics market size has grown strongly in recent years. It will grow from $32.82 billion in 2024 to $35.86 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising chronic diseases, medical innovation and research, growing acceptance of transplants, government initiatives and funding, improvements in biocompatibility.

The artificial organ and bionics market size is expected to see rapid growth in the next few years. It will grow to $56.11 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing healthcare expenditure, personalized medicine, regulatory support and streamlined approvals, rapid advancements in 3d printing, collaborations and partnerships. Major trends in the forecast period include miniaturization and wearable technology, technological advancements, advanced materials integration, ai and machine learning in design, 3d printing and bioprinting advancements.

The forecast of 11.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through shortages of German-made biocompatible membranes and Swiss precision micro-pumps, potentially delaying life-saving implant procedures and bionic limb development.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Increasing healthcare expenditure is anticipated to drive the growth of the artificial organ and bionics market in the future. Healthcare expenditure encompasses the total spending on health care and related activities, including both private and public health insurance, health research, and public health initiatives. Investments in healthcare facilitate technological innovations, leading to the development of more advanced and efficient artificial organs. This may involve enhancements in materials, design, and manufacturing processes. For example, in December 2023, the Centers for Medicare and Medicaid Services, a U.S. federal agency, reported that national health expenditures in the United States grew by 4.3% in 2022, up from a 2.7% increase in 2021. Consequently, rising healthcare expenditure is propelling the artificial organ and bionics market forward.

An increasing number of transplants is projected to drive the growth of the artificial organ and bionics market in the future. A transplant involves the surgical procedure where a tissue or organ is transferred from a donor to a recipient, or from one part of the body to another. Artificial organs are devices implanted in the body to replace damaged organs and replicate their specific functions, enabling patients to lead a normal life. For example, in January 2024, the Organ Procurement and Transplantation Network (OPTN), a U.S.-based organization, reported that in 2023, there were a total of 46,632 organ transplants performed using both living and deceased donors. This marked an 8.7% increase compared to 2022 and a 12.7% rise from 2021, the first year to surpass 40,000 transplants. Among these, 39,679 transplants were from deceased donors, reflecting an 8.9% increase from the previous year and setting a record for the eleventh consecutive year. Thus, the growing number of transplants is expected to significantly boost the artificial organ and bionics market.

Major corporate investments are steering the transformation of organ transplantation within the artificial organs and bionics market. These investments play a pivotal role in fostering the development of artificial organs, addressing the scarcity of donor organs by creating functional and biocompatible replacements. This not only offers hope to patients awaiting organ transplants but also holds the potential to revolutionize the landscape of transplantation medicine. An exemplar is the Government of Canada's investment of $2 million in April 2022 towards innovative organ and tissue donation projects, aimed at enhancing organ donation and transplantation efficacy in Canada. This funding aligns with the Networks of Centres of Excellence Program, dedicated to supporting organ donation and transplantation research.

Leading companies in the artificial organ and bionics market are advancing technologies like hearing devices to enhance connectivity, improve user experiences, and enable seamless integration between various devices. Hearing technology includes devices and solutions aimed at assisting individuals with hearing impairments, such as hearing aids and cochlear implants. For example, in November 2022, Cochlear Limited, an Australia-based medical device company, received approval from the U.S. Food and Drug Administration (FDA) for the Nucleus 8 Sound Processor. This device is designed to offer improved sound quality, enhanced connectivity, and user-friendly features, including compatibility with Bluetooth LE Audio technology. This innovation allows users to connect wirelessly to multiple devices, such as smartphones and televisions, creating a more integrated and streamlined listening experience.

In December 2022, Johnson & Johnson, a prominent healthcare products company based in the US, successfully acquired Abiomed Inc. for an undisclosed sum. This strategic acquisition is poised to expedite Johnson & Johnson's progress in providing cutting-edge medical technologies and advancing its MedTech business on a global scale. Abiomed Inc., also based in the US, operates within the sphere of artificial organs and bionics, making its acquisition a significant move for Johnson & Johnson as it aims to further its presence and innovation within this specialized domain.

Major companies operating in the artificial organ and bionics market include Abiomed Inc., Asahi Kasei Medical Co., Ltd, Baxter, Berlin Heart GmbH, Boston Scientific Corporation, Cyberonics Inc., Ekso Bionics Holdings Inc., Getinge AB, Medtronic PLC, Bornlife Prosthetic and Orthotic Inc., Sonova, LifeNet Health, Terumo Corporation, Nano Retina Ltd, Edwards Lifesciences Corporation, Orthofix Medical Inc, Cochlear Limited, Advanced Bionics AG, Ottobock SE & Co. KGaA, Second Sight Medical Products Inc., iWalk Inc., Jarvik Heart Inc, St. Jude Medical Inc., Harmonic Bionics Inc., Open Bionics, Beta Bionics Inc., Bionic Prosthetics and Orthotics, Mobius Bionics, Touch Bionics Ltd, Phytowelt GreenTechnologies GmbH

North America was the largest region in the artificial organ and bionics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global artificial organ and bionics market report during the forecast period. The regions covered in the artificial organ and bionics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial organ and bionics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial organs and bionics market consists of sales of artificial hearts, total artificial hearts (TAH), artificial kidneys, artificial livers, ear bionics, vision bionics, orthopaedic bionics, and heart bionics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Organ And Bionics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial organ and bionics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial organ and bionics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial organ and bionics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Artificial Organs; Artificial Bionics
  • 2) By Fixation Type: Implantable And Externally-Worn; Cardiac Bionics And Brain Bionics
  • 3) By Technology: Mechanical Bionics; Electronic Bionics
  • Subsegments:
  • 1) By Artificial Organs: Artificial Heart; Artificial Kidney; Artificial Liver; Artificial Pancreas; Artificial Lungs
  • 2) By Artificial Bionics: Bionic Limbs; Bionic Eyes; Exoskeletons; Neural Prosthetics
  • Companies Mentioned: Abiomed Inc.; Asahi Kasei Medical Co., Ltd; Baxter; Berlin Heart GmbH; Boston Scientific Corporation; Cyberonics Inc.; Ekso Bionics Holdings Inc.; Getinge AB; Medtronic PLC; Bornlife Prosthetic and Orthotic Inc.; Sonova; LifeNet Health; Terumo Corporation; Nano Retina Ltd; Edwards Lifesciences Corporation; Orthofix Medical Inc; Cochlear Limited; Advanced Bionics AG; Ottobock SE & Co. KGaA; Second Sight Medical Products Inc.; iWalk Inc.; Jarvik Heart Inc; St. Jude Medical Inc.; Harmonic Bionics Inc.; Open Bionics; Beta Bionics Inc.; Bionic Prosthetics and Orthotics; Mobius Bionics; Touch Bionics Ltd; Phytowelt GreenTechnologies GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Organ And Bionics Market Characteristics

3. Artificial Organ And Bionics Market Trends And Strategies

4. Artificial Organ And Bionics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Organ And Bionics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Organ And Bionics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Organ And Bionics Market Growth Rate Analysis
  • 5.4. Global Artificial Organ And Bionics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Organ And Bionics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Organ And Bionics Total Addressable Market (TAM)

6. Artificial Organ And Bionics Market Segmentation

  • 6.1. Global Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Artificial Organs
  • Artificial Bionics
  • 6.2. Global Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable And Externally-Worn
  • Cardiac Bionics And Brain Bionics
  • 6.3. Global Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mechanical Bionics
  • Electronic Bionics
  • Artificial Organ And Bionics
  • 6.4. Global Artificial Organ And Bionics Market, Sub-Segmentation Of Artificial Organs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Artificial Heart
  • Artificial Kidney
  • Artificial Liver
  • Artificial Pancreas
  • Artificial Lungs
  • 6.5. Global Artificial Organ And Bionics Market, Sub-Segmentation Of Artificial Bionics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bionic Limbs
  • Bionic Eyes
  • Exoskeletons
  • Neural Prosthetics

7. Artificial Organ And Bionics Market Regional And Country Analysis

  • 7.1. Global Artificial Organ And Bionics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Organ And Bionics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Organ And Bionics Market

  • 8.1. Asia-Pacific Artificial Organ And Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Organ And Bionics Market

  • 9.1. China Artificial Organ And Bionics Market Overview
  • 9.2. China Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Organ And Bionics Market

  • 10.1. India Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Organ And Bionics Market

  • 11.1. Japan Artificial Organ And Bionics Market Overview
  • 11.2. Japan Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Organ And Bionics Market

  • 12.1. Australia Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Organ And Bionics Market

  • 13.1. Indonesia Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Organ And Bionics Market

  • 14.1. South Korea Artificial Organ And Bionics Market Overview
  • 14.2. South Korea Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Organ And Bionics Market

  • 15.1. Western Europe Artificial Organ And Bionics Market Overview
  • 15.2. Western Europe Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Organ And Bionics Market

  • 16.1. UK Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Organ And Bionics Market

  • 17.1. Germany Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Organ And Bionics Market

  • 18.1. France Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Organ And Bionics Market

  • 19.1. Italy Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Organ And Bionics Market

  • 20.1. Spain Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Organ And Bionics Market

  • 21.1. Eastern Europe Artificial Organ And Bionics Market Overview
  • 21.2. Eastern Europe Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Organ And Bionics Market

  • 22.1. Russia Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Organ And Bionics Market

  • 23.1. North America Artificial Organ And Bionics Market Overview
  • 23.2. North America Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Organ And Bionics Market

  • 24.1. USA Artificial Organ And Bionics Market Overview
  • 24.2. USA Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Organ And Bionics Market

  • 25.1. Canada Artificial Organ And Bionics Market Overview
  • 25.2. Canada Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Organ And Bionics Market

  • 26.1. South America Artificial Organ And Bionics Market Overview
  • 26.2. South America Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Organ And Bionics Market

  • 27.1. Brazil Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Organ And Bionics Market

  • 28.1. Middle East Artificial Organ And Bionics Market Overview
  • 28.2. Middle East Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Organ And Bionics Market

  • 29.1. Africa Artificial Organ And Bionics Market Overview
  • 29.2. Africa Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Organ And Bionics Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Organ And Bionics Market Competitive Landscape
  • 30.2. Artificial Organ And Bionics Market Company Profiles
    • 30.2.1. Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Asahi Kasei Medical Co., Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Baxter Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Berlin Heart GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Organ And Bionics Market Other Major And Innovative Companies

  • 31.1. Cyberonics Inc.
  • 31.2. Ekso Bionics Holdings Inc.
  • 31.3. Getinge AB
  • 31.4. Medtronic PLC
  • 31.5. Bornlife Prosthetic and Orthotic Inc.
  • 31.6. Sonova
  • 31.7. LifeNet Health
  • 31.8. Terumo Corporation
  • 31.9. Nano Retina Ltd
  • 31.10. Edwards Lifesciences Corporation
  • 31.11. Orthofix Medical Inc
  • 31.12. Cochlear Limited
  • 31.13. Advanced Bionics AG
  • 31.14. Ottobock SE & Co. KGaA
  • 31.15. Second Sight Medical Products Inc.

32. Global Artificial Organ And Bionics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Organ And Bionics Market

34. Recent Developments In The Artificial Organ And Bionics Market

35. Artificial Organ And Bionics Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Organ And Bionics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Organ And Bionics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Organ And Bionics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer